The FDA Peptide Vote: What the Committee Decided on July 23–24
Quick answer: The FDA’s Pharmacy Compounding Advisory Committee met July 23 and 24, 2026 and recommended six of seven peptides for the 503A Bulks List: BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon. Emideltide, also called DSIP, was rejected. Every vote was close, and the committee went against its own FDA staff’s written recommendation on all…
Details










